Literature DB >> 7410635

Computed tomography for diagnosis of empty sella associated with enhancing pituitary microadenoma.

F Smaltino, F P Bernini, I Muras.   

Abstract

Ten cases of primary empty sella with clinical findings of a secreting pituitary adenoma were studied using computed tomography (CT). Scans performed before contrast medium infusion confirmed the diagnosis of empty sella. After infusion, eight cases were found to have a nodular area of increased density within the sella turcica. In two patients, the enhancement probably corresponded to the pituitary stalk; the other six patients demonstrated CT evidence of pituitary microadenoma. These six patients had surgical confirmation of the existence of neoplasm. Tomodensitometric diagnosis of empty sella combined with microadenoma allows transsphenoidal microsurgery for complete tumor removal with preservation of the residual pituitary gland. For comparison, in a series of 21 patients suspected of having microadenomas, but without evidence of empty or enlarged sella, enhancing microadenomas were shown in 13 (62%).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410635     DOI: 10.1097/00004728-198010000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Spontaneous CSF rhinorrhea through the lamina cribrosa associated with primary empty sella.

Authors:  D Perani; G Scotti; N Colombo; R Sterzi; A Castelli
Journal:  Ital J Neurol Sci       Date:  1984-06

2.  Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatment.

Authors:  G Scotti; G Scialfa; S Pieralli; P G Chiodini; B Spelta; D Dallabonzana
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

3.  CT abnormalities of the pituitary in hyperprolactinaemic women with normal or equivocal sellae radiologically.

Authors:  R T Jung; M C White; N B Bowley; G Bydder; K Mashiter; G F Joplin
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.